SlideShare uma empresa Scribd logo
1 de 12
CORONARY ARTERY DISEASE AMONG ASYMPTOMATIC DIABETIC AND NONDIABETIC PATIENTS  UNDERGOING CORONARY CT ANGIOGRAPHY   Zeina AR, Blinder J, Rosenschein U,  Zaid G ,   Barmeir E _______________________________________________________________________________ Zeina et al, Coronary Artery Disease 2008, 19:37–41
[object Object],[object Object],[object Object],_______________________________________________________________________________ ,[object Object],[object Object],[object Object],Zeina et al, Coronary Artery Disease 2008, 19:37–41 Introduction
[object Object],[object Object],[object Object],[object Object],_______________________________________________________________________________ Zeina et al, Coronary Artery Disease 2008, 19:37–41 Introduction
The aim of this study was to determine the prevalence and severity of CAD and the plaque composition in asymptomatic diabetic patients undergoing coronary CT angiography (CCTA)   _______________________________________________________________________________ Purpose Zeina et al, Coronary Artery Disease 2008, 19:37–41
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Materials and Methods _______________________________________________________________________________ Zeina et al, Coronary Artery Disease 2008, 19:37–41
Table 1. Baseline characteristics of diabetic and non-diabetic patients. _______________________________________________________________________________ Zeina et al, Coronary Artery Disease 2008, 19:37–41 0.96 101 (35) 15 (36) Smoking, n (%) 0.34 152 (53) 19 (45) Hyperlipidemia, n (%) 0.17 138 (48) 25 (59) Hypertension, n (%) 0.19 126 (44) 14 (33) Family history, n (%) 0.17  213 (74) 38 (90) Male gender, n (%) 0.10 56 ± 9 58 ± 8 Age (years ± SD) (N= 286) (N= 42)  P value Non-diabetic patients Diabetic patients
[object Object],[object Object],[object Object],[object Object],[object Object],_______________________________________________________________________________ Materials and Methods Zeina et al, Coronary Artery Disease 2008, 19:37–41
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],_______________________________________________________________________________ Results Zeina et al, Coronary Artery Disease 2008, 19:37–41
Table 2. CCTA characteristics of the study population and comparison between diabetic and non-diabetic patients. * P  value < 0.05 is considered significant. CCTA= coronary CT angiography _______________________________________________________________________________ Results Zeina et al, Coronary Artery Disease 2008, 19:37–41 0.1 1 (0.3%) 1 (2%) Three-vessel disease 0.3 2 (0.7%) 1 (2%) Two-vessel disease < 0.0001 16 (5.6%) 10 (24%) One-vessel disease  < 0.0001 2.8 5.5  Segments with plaques/patient 0.07 141 (49%) 27 (64%) Non-obstructive CAD < 0.0001 19 (6.6%) 12 (29%) Obstructive CAD  0.006 211 (74%)  39 (93%) Coronary plaques < 0.0001  79.9 ± 16 370 ± 96  Total Agatston score (n= 286) (n= 42) P  value *   Non-diabetic patients Diabetic patients
54-year-old asymptomatic diabetic patient  MIP 3D-VR CCTA Zeina et al, Coronary Artery Disease 2008, 19:37–41
Discussion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],_______________________________________________________________________________ Zeina et al, Coronary Artery Disease 2008, 19:37–41
[object Object],[object Object],[object Object],_______________________________________________________________________________ Conclusion ,[object Object],[object Object],[object Object],Zeina et al, Coronary Artery Disease 2008, 19:37–41

Mais conteúdo relacionado

Mais procurados

Thierry Chassaulet: Predictive risk modelling: Does technique or time matter?
Thierry Chassaulet: Predictive risk modelling: Does technique or time matter?Thierry Chassaulet: Predictive risk modelling: Does technique or time matter?
Thierry Chassaulet: Predictive risk modelling: Does technique or time matter?
Nuffield Trust
 
Ije Okafor_Poster
Ije Okafor_PosterIje Okafor_Poster
Ije Okafor_Poster
Ije Okafor
 
How Much Does A Hospital Day Cost?
How Much Does A Hospital Day Cost?How Much Does A Hospital Day Cost?
How Much Does A Hospital Day Cost?
clearflow
 
12471_2015_Article_733
12471_2015_Article_73312471_2015_Article_733
12471_2015_Article_733
Brian Vendel
 
Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...
Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...
Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...
Mutiple Sclerosis
 

Mais procurados (20)

Base Primary Prevention Decision Model
Base Primary Prevention Decision ModelBase Primary Prevention Decision Model
Base Primary Prevention Decision Model
 
Thierry Chassaulet: Predictive risk modelling: Does technique or time matter?
Thierry Chassaulet: Predictive risk modelling: Does technique or time matter?Thierry Chassaulet: Predictive risk modelling: Does technique or time matter?
Thierry Chassaulet: Predictive risk modelling: Does technique or time matter?
 
Dores et al
Dores et alDores et al
Dores et al
 
Measuring long term effect of Telecare on Chronic Diseases by Masatugu Tsuji,
Measuring long term effect of Telecare on Chronic Diseases by Masatugu Tsuji,Measuring long term effect of Telecare on Chronic Diseases by Masatugu Tsuji,
Measuring long term effect of Telecare on Chronic Diseases by Masatugu Tsuji,
 
Ije Okafor_Poster
Ije Okafor_PosterIje Okafor_Poster
Ije Okafor_Poster
 
Outcomes of Carotid Stent Systems Versus Endarterectomy 4.29.08
Outcomes of Carotid Stent Systems Versus Endarterectomy 4.29.08Outcomes of Carotid Stent Systems Versus Endarterectomy 4.29.08
Outcomes of Carotid Stent Systems Versus Endarterectomy 4.29.08
 
Purple and white modern advertising presentation
Purple and white modern advertising presentationPurple and white modern advertising presentation
Purple and white modern advertising presentation
 
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...
 
Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke
Central Adiposity and Mortality after First-Ever Acute Ischemic StrokeCentral Adiposity and Mortality after First-Ever Acute Ischemic Stroke
Central Adiposity and Mortality after First-Ever Acute Ischemic Stroke
 
Critical Illness Outcomes in General Versus Specialty Intensive Care Units 5....
Critical Illness Outcomes in General Versus Specialty Intensive Care Units 5....Critical Illness Outcomes in General Versus Specialty Intensive Care Units 5....
Critical Illness Outcomes in General Versus Specialty Intensive Care Units 5....
 
How Much Does A Hospital Day Cost?
How Much Does A Hospital Day Cost?How Much Does A Hospital Day Cost?
How Much Does A Hospital Day Cost?
 
12471_2015_Article_733
12471_2015_Article_73312471_2015_Article_733
12471_2015_Article_733
 
Risk factors for adverse coutcomes
Risk factors for adverse coutcomesRisk factors for adverse coutcomes
Risk factors for adverse coutcomes
 
Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...
Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...
Novel Method for Automated Analysis of Retinal Images: Results in Subjects wi...
 
The Effect of Demographic Data and Hemoglobin A 1c on Treatment Outcomes in P...
The Effect of Demographic Data and Hemoglobin A 1c on Treatment Outcomes in P...The Effect of Demographic Data and Hemoglobin A 1c on Treatment Outcomes in P...
The Effect of Demographic Data and Hemoglobin A 1c on Treatment Outcomes in P...
 
Seattle heart failure model
Seattle heart failure modelSeattle heart failure model
Seattle heart failure model
 
HEC 2014 / James Peake: The Quality Journey of the U.S. Department of Veteran...
HEC 2014 / James Peake: The Quality Journey of the U.S. Department of Veteran...HEC 2014 / James Peake: The Quality Journey of the U.S. Department of Veteran...
HEC 2014 / James Peake: The Quality Journey of the U.S. Department of Veteran...
 
Differences in clinical characteristics and its effect for outcomes
Differences in clinical characteristics and its effect for outcomesDifferences in clinical characteristics and its effect for outcomes
Differences in clinical characteristics and its effect for outcomes
 
Ischemia Trial
Ischemia TrialIschemia Trial
Ischemia Trial
 
Stopdapt 2 randomized clinical trial
Stopdapt 2 randomized clinical trialStopdapt 2 randomized clinical trial
Stopdapt 2 randomized clinical trial
 

Destaque

204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
SHAPE Society
 
120 mr imaging for the evaluation of carotid atherosclerosis
120 mr imaging for the evaluation of carotid atherosclerosis120 mr imaging for the evaluation of carotid atherosclerosis
120 mr imaging for the evaluation of carotid atherosclerosis
SHAPE Society
 
213 oral apo ai mimetic peptide for reduction of atherosclerosis
213 oral apo ai mimetic peptide for reduction of atherosclerosis213 oral apo ai mimetic peptide for reduction of atherosclerosis
213 oral apo ai mimetic peptide for reduction of atherosclerosis
SHAPE Society
 
134 mr contrast agents for vulnerable plaque imaging
134 mr contrast agents for vulnerable plaque imaging134 mr contrast agents for vulnerable plaque imaging
134 mr contrast agents for vulnerable plaque imaging
SHAPE Society
 

Destaque (20)

204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
204 prevalence of inflammatory cells in non ruptured atherosclerotic plaques
 
048 adventitial fat presentation
048 adventitial fat presentation048 adventitial fat presentation
048 adventitial fat presentation
 
225 animal models of heart attack part 2
225 animal models of heart attack part 2225 animal models of heart attack part 2
225 animal models of heart attack part 2
 
120 mr imaging for the evaluation of carotid atherosclerosis
120 mr imaging for the evaluation of carotid atherosclerosis120 mr imaging for the evaluation of carotid atherosclerosis
120 mr imaging for the evaluation of carotid atherosclerosis
 
213 oral apo ai mimetic peptide for reduction of atherosclerosis
213 oral apo ai mimetic peptide for reduction of atherosclerosis213 oral apo ai mimetic peptide for reduction of atherosclerosis
213 oral apo ai mimetic peptide for reduction of atherosclerosis
 
108 cetp expression
108 cetp expression108 cetp expression
108 cetp expression
 
185 towards the future cath lab
185 towards the future cath lab185 towards the future cath lab
185 towards the future cath lab
 
125 ct based characterization
125 ct based characterization125 ct based characterization
125 ct based characterization
 
034 everybody has atherosclerosis
034 everybody has atherosclerosis034 everybody has atherosclerosis
034 everybody has atherosclerosis
 
No correlation and low agreement of imaging and inflammatory atherosclerosis’...
No correlation and low agreement of imaging and inflammatory atherosclerosis’...No correlation and low agreement of imaging and inflammatory atherosclerosis’...
No correlation and low agreement of imaging and inflammatory atherosclerosis’...
 
117 mr images of human carotid arteries
117 mr images of human carotid arteries117 mr images of human carotid arteries
117 mr images of human carotid arteries
 
134 mr contrast agents for vulnerable plaque imaging
134 mr contrast agents for vulnerable plaque imaging134 mr contrast agents for vulnerable plaque imaging
134 mr contrast agents for vulnerable plaque imaging
 
089 intravascular magnetic resonance imaging
089 intravascular magnetic resonance imaging089 intravascular magnetic resonance imaging
089 intravascular magnetic resonance imaging
 
257 inhibition of atherosclerosis in mice
257 inhibition of atherosclerosis in mice257 inhibition of atherosclerosis in mice
257 inhibition of atherosclerosis in mice
 
144 physics of mri
144 physics of mri144 physics of mri
144 physics of mri
 
253 endothelial dysfunction
253 endothelial dysfunction253 endothelial dysfunction
253 endothelial dysfunction
 
3rd vulnerable plaque rumberger 3 16-02 3
3rd vulnerable plaque rumberger 3 16-02 33rd vulnerable plaque rumberger 3 16-02 3
3rd vulnerable plaque rumberger 3 16-02 3
 
230 plaque crp or myocardial crp
230 plaque crp or myocardial crp230 plaque crp or myocardial crp
230 plaque crp or myocardial crp
 
219 coronary autoregulation in vivo
219 coronary autoregulation in vivo219 coronary autoregulation in vivo
219 coronary autoregulation in vivo
 
249 the most cost effective therapy
249 the most cost effective therapy249 the most cost effective therapy
249 the most cost effective therapy
 

Semelhante a Coronary artery disease among asymptomatic diabetic and non-diabetic patients undergoing coronary CT angiography

Screening for asymptomatic cad in diabetes
Screening for asymptomatic cad in diabetesScreening for asymptomatic cad in diabetes
Screening for asymptomatic cad in diabetes
Shyam Jadhav
 
Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...
Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...
Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...
Premier Publishers
 
Stable angina
Stable anginaStable angina
Stable angina
Ramachandra Barik
 
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
MedicineAndHealthUSA
 

Semelhante a Coronary artery disease among asymptomatic diabetic and non-diabetic patients undergoing coronary CT angiography (20)

Ueda 2016 dm &amp; cad-amr el hadidy
Ueda 2016 dm &amp; cad-amr el hadidyUeda 2016 dm &amp; cad-amr el hadidy
Ueda 2016 dm &amp; cad-amr el hadidy
 
Screening for asymptomatic cad in diabetes
Screening for asymptomatic cad in diabetesScreening for asymptomatic cad in diabetes
Screening for asymptomatic cad in diabetes
 
Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...
Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...
Clinical Profile of Patients with Coronary Tortuosity and its Relation with C...
 
Racial Differences in Access to New Technology 4.29.08
Racial Differences in Access to New Technology 4.29.08Racial Differences in Access to New Technology 4.29.08
Racial Differences in Access to New Technology 4.29.08
 
Diabetic kidney disease 2021
Diabetic kidney disease 2021 Diabetic kidney disease 2021
Diabetic kidney disease 2021
 
Trends in diabetes-related health indicators in Aboriginal communities in Nor...
Trends in diabetes-related health indicators in Aboriginal communities in Nor...Trends in diabetes-related health indicators in Aboriginal communities in Nor...
Trends in diabetes-related health indicators in Aboriginal communities in Nor...
 
Predictors of persistence with antihypertensive therapy: results from the NHANES
Predictors of persistence with antihypertensive therapy: results from the NHANESPredictors of persistence with antihypertensive therapy: results from the NHANES
Predictors of persistence with antihypertensive therapy: results from the NHANES
 
Stable angina
Stable anginaStable angina
Stable angina
 
Objetivos en diabetes: de la "evidencia" al sentido común
Objetivos en diabetes: de la "evidencia" al sentido común Objetivos en diabetes: de la "evidencia" al sentido común
Objetivos en diabetes: de la "evidencia" al sentido común
 
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
 
Diabetes Care
Diabetes CareDiabetes Care
Diabetes Care
 
Cardiovascular.pptx slide for detection cancer
Cardiovascular.pptx slide for detection cancerCardiovascular.pptx slide for detection cancer
Cardiovascular.pptx slide for detection cancer
 
BP Targets-where are we now.pptx
BP Targets-where are we now.pptxBP Targets-where are we now.pptx
BP Targets-where are we now.pptx
 
clopidogril and ACS
clopidogril and ACSclopidogril and ACS
clopidogril and ACS
 
Hyvet Slide Set
Hyvet Slide SetHyvet Slide Set
Hyvet Slide Set
 
A STUDY ON PREVALENCE OF MICRO AND MACRO VASCULAR COMPLICATIONS IN TYPE 2 DI...
A STUDY ON PREVALENCE OF MICRO AND MACRO VASCULAR  COMPLICATIONS IN TYPE 2 DI...A STUDY ON PREVALENCE OF MICRO AND MACRO VASCULAR  COMPLICATIONS IN TYPE 2 DI...
A STUDY ON PREVALENCE OF MICRO AND MACRO VASCULAR COMPLICATIONS IN TYPE 2 DI...
 
Ndei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes EpidemiologyNdei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes Epidemiology
 
Sympo.grandes.etudes.algerie.2020.version.04.ppt
Sympo.grandes.etudes.algerie.2020.version.04.pptSympo.grandes.etudes.algerie.2020.version.04.ppt
Sympo.grandes.etudes.algerie.2020.version.04.ppt
 
The Science Diabetes Control
The Science Diabetes ControlThe Science Diabetes Control
The Science Diabetes Control
 
Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..
 

Mais de SHAPE Society (20)

Barth imt
Barth imtBarth imt
Barth imt
 
Braunwald
BraunwaldBraunwald
Braunwald
 
Acc vp-org 3-02 stone
Acc vp-org 3-02 stoneAcc vp-org 3-02 stone
Acc vp-org 3-02 stone
 
101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 f
 
Acc v porg becker
Acc v porg beckerAcc v porg becker
Acc v porg becker
 
Acc 2005-1, v pl-vp
Acc 2005-1, v pl-vpAcc 2005-1, v pl-vp
Acc 2005-1, v pl-vp
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
 
Acc v porg
Acc v porgAcc v porg
Acc v porg
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
 
Ac cculprit
Ac cculpritAc cculprit
Ac cculprit
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for print
 
Acc booth inventory
Acc booth inventoryAcc booth inventory
Acc booth inventory
 
Acc 04 vuln pt
Acc 04 vuln ptAcc 04 vuln pt
Acc 04 vuln pt
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for print
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
 
A20 gene
A20 geneA20 gene
A20 gene
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosis
 
103100
103100103100
103100
 

Último

Call Girls From Pari Chowk Greater Noida ❤️8448577510 ⊹Best Escorts Service I...
Call Girls From Pari Chowk Greater Noida ❤️8448577510 ⊹Best Escorts Service I...Call Girls From Pari Chowk Greater Noida ❤️8448577510 ⊹Best Escorts Service I...
Call Girls From Pari Chowk Greater Noida ❤️8448577510 ⊹Best Escorts Service I...
lizamodels9
 
FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756
FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756
FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756
dollysharma2066
 
Call Girls In DLf Gurgaon ➥99902@11544 ( Best price)100% Genuine Escort In 24...
Call Girls In DLf Gurgaon ➥99902@11544 ( Best price)100% Genuine Escort In 24...Call Girls In DLf Gurgaon ➥99902@11544 ( Best price)100% Genuine Escort In 24...
Call Girls In DLf Gurgaon ➥99902@11544 ( Best price)100% Genuine Escort In 24...
lizamodels9
 
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
Renandantas16
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
Abortion pills in Kuwait Cytotec pills in Kuwait
 
Insurers' journeys to build a mastery in the IoT usage
Insurers' journeys to build a mastery in the IoT usageInsurers' journeys to build a mastery in the IoT usage
Insurers' journeys to build a mastery in the IoT usage
Matteo Carbone
 
Call Girls Jp Nagar Just Call 👗 7737669865 👗 Top Class Call Girl Service Bang...
Call Girls Jp Nagar Just Call 👗 7737669865 👗 Top Class Call Girl Service Bang...Call Girls Jp Nagar Just Call 👗 7737669865 👗 Top Class Call Girl Service Bang...
Call Girls Jp Nagar Just Call 👗 7737669865 👗 Top Class Call Girl Service Bang...
amitlee9823
 
Russian Call Girls In Gurgaon ❤️8448577510 ⊹Best Escorts Service In 24/7 Delh...
Russian Call Girls In Gurgaon ❤️8448577510 ⊹Best Escorts Service In 24/7 Delh...Russian Call Girls In Gurgaon ❤️8448577510 ⊹Best Escorts Service In 24/7 Delh...
Russian Call Girls In Gurgaon ❤️8448577510 ⊹Best Escorts Service In 24/7 Delh...
lizamodels9
 
Call Girls in Delhi, Escort Service Available 24x7 in Delhi 959961-/-3876
Call Girls in Delhi, Escort Service Available 24x7 in Delhi 959961-/-3876Call Girls in Delhi, Escort Service Available 24x7 in Delhi 959961-/-3876
Call Girls in Delhi, Escort Service Available 24x7 in Delhi 959961-/-3876
dlhescort
 
Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...
Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...
Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...
Sheetaleventcompany
 

Último (20)

Call Girls From Pari Chowk Greater Noida ❤️8448577510 ⊹Best Escorts Service I...
Call Girls From Pari Chowk Greater Noida ❤️8448577510 ⊹Best Escorts Service I...Call Girls From Pari Chowk Greater Noida ❤️8448577510 ⊹Best Escorts Service I...
Call Girls From Pari Chowk Greater Noida ❤️8448577510 ⊹Best Escorts Service I...
 
FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756
FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756
FULL ENJOY Call Girls In Majnu Ka Tilla, Delhi Contact Us 8377877756
 
Call Girls In DLf Gurgaon ➥99902@11544 ( Best price)100% Genuine Escort In 24...
Call Girls In DLf Gurgaon ➥99902@11544 ( Best price)100% Genuine Escort In 24...Call Girls In DLf Gurgaon ➥99902@11544 ( Best price)100% Genuine Escort In 24...
Call Girls In DLf Gurgaon ➥99902@11544 ( Best price)100% Genuine Escort In 24...
 
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf0183760ssssssssssssssssssssssssssss00101011 (27).pdf
0183760ssssssssssssssssssssssssssss00101011 (27).pdf
 
Call Girls Service In Old Town Dubai ((0551707352)) Old Town Dubai Call Girl ...
Call Girls Service In Old Town Dubai ((0551707352)) Old Town Dubai Call Girl ...Call Girls Service In Old Town Dubai ((0551707352)) Old Town Dubai Call Girl ...
Call Girls Service In Old Town Dubai ((0551707352)) Old Town Dubai Call Girl ...
 
Business Model Canvas (BMC)- A new venture concept
Business Model Canvas (BMC)-  A new venture conceptBusiness Model Canvas (BMC)-  A new venture concept
Business Model Canvas (BMC)- A new venture concept
 
Famous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st CenturyFamous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st Century
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
 
Insurers' journeys to build a mastery in the IoT usage
Insurers' journeys to build a mastery in the IoT usageInsurers' journeys to build a mastery in the IoT usage
Insurers' journeys to build a mastery in the IoT usage
 
Call Girls Jp Nagar Just Call 👗 7737669865 👗 Top Class Call Girl Service Bang...
Call Girls Jp Nagar Just Call 👗 7737669865 👗 Top Class Call Girl Service Bang...Call Girls Jp Nagar Just Call 👗 7737669865 👗 Top Class Call Girl Service Bang...
Call Girls Jp Nagar Just Call 👗 7737669865 👗 Top Class Call Girl Service Bang...
 
Russian Call Girls In Gurgaon ❤️8448577510 ⊹Best Escorts Service In 24/7 Delh...
Russian Call Girls In Gurgaon ❤️8448577510 ⊹Best Escorts Service In 24/7 Delh...Russian Call Girls In Gurgaon ❤️8448577510 ⊹Best Escorts Service In 24/7 Delh...
Russian Call Girls In Gurgaon ❤️8448577510 ⊹Best Escorts Service In 24/7 Delh...
 
Call Girls In Panjim North Goa 9971646499 Genuine Service
Call Girls In Panjim North Goa 9971646499 Genuine ServiceCall Girls In Panjim North Goa 9971646499 Genuine Service
Call Girls In Panjim North Goa 9971646499 Genuine Service
 
A DAY IN THE LIFE OF A SALESMAN / WOMAN
A DAY IN THE LIFE OF A  SALESMAN / WOMANA DAY IN THE LIFE OF A  SALESMAN / WOMAN
A DAY IN THE LIFE OF A SALESMAN / WOMAN
 
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfDr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
 
Call Girls in Delhi, Escort Service Available 24x7 in Delhi 959961-/-3876
Call Girls in Delhi, Escort Service Available 24x7 in Delhi 959961-/-3876Call Girls in Delhi, Escort Service Available 24x7 in Delhi 959961-/-3876
Call Girls in Delhi, Escort Service Available 24x7 in Delhi 959961-/-3876
 
It will be International Nurses' Day on 12 May
It will be International Nurses' Day on 12 MayIt will be International Nurses' Day on 12 May
It will be International Nurses' Day on 12 May
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentation
 
Phases of Negotiation .pptx
 Phases of Negotiation .pptx Phases of Negotiation .pptx
Phases of Negotiation .pptx
 
RSA Conference Exhibitor List 2024 - Exhibitors Data
RSA Conference Exhibitor List 2024 - Exhibitors DataRSA Conference Exhibitor List 2024 - Exhibitors Data
RSA Conference Exhibitor List 2024 - Exhibitors Data
 
Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...
Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...
Chandigarh Escorts Service 📞8868886958📞 Just📲 Call Nihal Chandigarh Call Girl...
 

Coronary artery disease among asymptomatic diabetic and non-diabetic patients undergoing coronary CT angiography

  • 1. CORONARY ARTERY DISEASE AMONG ASYMPTOMATIC DIABETIC AND NONDIABETIC PATIENTS UNDERGOING CORONARY CT ANGIOGRAPHY Zeina AR, Blinder J, Rosenschein U, Zaid G , Barmeir E _______________________________________________________________________________ Zeina et al, Coronary Artery Disease 2008, 19:37–41
  • 2.
  • 3.
  • 4. The aim of this study was to determine the prevalence and severity of CAD and the plaque composition in asymptomatic diabetic patients undergoing coronary CT angiography (CCTA) _______________________________________________________________________________ Purpose Zeina et al, Coronary Artery Disease 2008, 19:37–41
  • 5.
  • 6. Table 1. Baseline characteristics of diabetic and non-diabetic patients. _______________________________________________________________________________ Zeina et al, Coronary Artery Disease 2008, 19:37–41 0.96 101 (35) 15 (36) Smoking, n (%) 0.34 152 (53) 19 (45) Hyperlipidemia, n (%) 0.17 138 (48) 25 (59) Hypertension, n (%) 0.19 126 (44) 14 (33) Family history, n (%) 0.17 213 (74) 38 (90) Male gender, n (%) 0.10 56 ± 9 58 ± 8 Age (years ± SD) (N= 286) (N= 42) P value Non-diabetic patients Diabetic patients
  • 7.
  • 8.
  • 9. Table 2. CCTA characteristics of the study population and comparison between diabetic and non-diabetic patients. * P value < 0.05 is considered significant. CCTA= coronary CT angiography _______________________________________________________________________________ Results Zeina et al, Coronary Artery Disease 2008, 19:37–41 0.1 1 (0.3%) 1 (2%) Three-vessel disease 0.3 2 (0.7%) 1 (2%) Two-vessel disease < 0.0001 16 (5.6%) 10 (24%) One-vessel disease < 0.0001 2.8 5.5 Segments with plaques/patient 0.07 141 (49%) 27 (64%) Non-obstructive CAD < 0.0001 19 (6.6%) 12 (29%) Obstructive CAD 0.006 211 (74%) 39 (93%) Coronary plaques < 0.0001 79.9 ± 16 370 ± 96 Total Agatston score (n= 286) (n= 42) P value * Non-diabetic patients Diabetic patients
  • 10. 54-year-old asymptomatic diabetic patient MIP 3D-VR CCTA Zeina et al, Coronary Artery Disease 2008, 19:37–41
  • 11.
  • 12.